Biotechnologies Assets S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BST.MC research report →
Price Chart
About the company
Biotechnologies Assets S. A. is dedicated to conceiving, producing, and commercializing sophisticated biotechnological assets.
- CEO
- Manuel Lopez Nieto
- IPO
- 2012
- Employees
- 26
- HQ
- Cádiz, AN, ES
Get TickerSpark's AI analysis on BST.MC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $15.89M
- P/E
- -7.79
- PEG
- -0.16
- P/S
- 5.14
- P/B
- 2.49
- EV/EBITDA
- 32.98
- Div Yield
- 0.00%
- Gross Margin
- -16.57%
- Op Margin
- -61.59%
- Net Margin
- -61.99%
- ROE
- -32.40%
- ROIC
- -15.87%
Latest fiscal year · YoY change
- Revenue
- $3.09M+22.9%
- Gross Profit
- $-512,158-119.3%
- Op Income
- $-1,903,571
- Net Income
- $-1,916,063+34.3%
- EPS
- $-0.03+40.9%
- OCF Growth
- +82.2%
- FCF Growth
- +98.1%
- 52W High
- $0.47
- 52W Low
- $0.18
- 50D MA
- $0.22
- 200D MA
- $0.23
- Beta
- 1.82
- RSI (14)
- 41
- Avg Volume
- 127.33K
No earnings-call transcripts are available for BST.MC yet.
- Free Float
- 47.0%
- Shares Outstanding
- 74.96M
- Float Shares
- 35.25M
Our BST.MC coverage
Recent articles, reports, and earnings notes.
No research on BST.MC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BST.MC report →